Delivery Order SPE2DP20D0002-SPE2DP25F2792
Award Date
1/28/25
Potential Completion Date
2/4/25
Potential Value
$1.2M
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, in the amount of $330,313.86. The contract is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The award has an ultimate completion date of February 4, 2025. Teva Pharmaceuticals USA, Inc. is a large business and the contract is not set aside. The company also holds two...
This is a $476,414.19 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines, which support military immunization programs. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various U.S. federal government agencies, including the Department of Veterans...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $158,804.73, is for the delivery of Adenovirus Type 4 vaccine, a critical product that supports military immunization programs. The contract has a period of performance through July 30, 2024 and is a firm-fixed-price type. Teva Pharmaceuticals USA, Inc. has received multiple delivery orders...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $158,804.73, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract has a final completion date of September 24, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 contract, which has no set-aside designation, is for the supply of Adenovirus Type 4 A vaccine with a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. has been awarded multiple federal contracts and delivery orders from agencies like the Department of Veterans...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract has a ceiling value of $317,609.46 and a period of performance through November 19, 2024. The award is unrestricted, meaning Teva competed as a large business without any set-aside designations. Teva is a major pharmaceutical supplier to federal...
This is a firm fixed-price delivery order awarded to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Defense Logistics Agency (DLA) Troop Support Medical. The $158,804.73 contract is for the supply of Adenovirus Type 4 vaccines, with a performance period running through June 25, 2024. Teva Pharmaceuticals USA, Inc. is not designated under any set-aside program for this award. This delivery order is part of Teva's broader role as a prime...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $635,218.92, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. This award is not a set-aside and Teva, as a large business, competed without any small business designations. Teva is a major supplier of critical...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $3,176,094.60, is for the supply of Adenovirus Type 4 vaccine, which supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and is a major supplier of critical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The $317,609.46 firm-fixed-price contract has a completion date of November 19, 2024. Teva Pharmaceuticals is a major supplier of critical medical products to federal agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD),...